Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation

Oncogene

Volumn 33, Issue 4, 2014, Pages 495-503

  Marcos Villar, L ^a   Gallego, P ^a   Munoz Fontela C ^b   De La Cruz Herrera, C F ^a   Campagna, M ^a   Gonzalez D ^a   Lopitz Otsoa, F ^c   Rodriguez M S ^c,d   Rivas, C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Inbiomed   (Spain)

Author keywords

KSHV; LANA2; LXCXE domain; Pocket proteins; Sumoylation

Indexed keywords

LANA2 PROTEIN; POCKET PROTEIN; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; BCAR1 PROTEIN, HUMAN; CRK ASSOCIATED SUBSTRATE PROTEIN; INTERFERON REGULATORY FACTOR; RBL1 PROTEIN, HUMAN; VIRAL INTERFERON REGULATORY FACTORS;

ARTICLE; CELL CYCLE ARREST; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SUMOYLATION; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CRK-ASSOCIATED SUBSTRATE PROTEIN; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOPRECIPITATION; INTERFERON REGULATORY FACTORS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; SUMOYLATION; VIRAL PROTEINS;

EID: 84883261196     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.603     Document Type: Article

References (73)

1. Ewen ME, Xing YG, Lawrence JB, Livingston DM. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 1991; 66: 1155-1164.
2. Hannon GJ, Demetrick D, Beach D. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 1993; 7: 2378-2391.
3. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. The adenovirus E1A-associated 130- kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 1993; 7: 2366-2377.
4. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 1993; 8: 2561-2566.
5. Dyson N, Harlow E. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv 1992; 12: 161-195.
6. Claudio PP, De Luca A, Howard CM, Baldi A, Firpo EJ, Koff A et al. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 1996; 56: 2003-2008.
7. Beijersbergen RL, Carlee L, Kerkhoven RM, Bernards R. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev 1995; 9: 1340-1353.
8. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65: 1053-1061.
9. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998; 18: 753-761.
10. Smith EJ, Leone G, Nevins JR. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ 1998; 9: 297-303.
11. Xiao ZX, Ginsberg D, Ewen M, Livingston DM. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci USA 1996; 93: 4633-4637.
12. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8: 671-682.
13. Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 2001; 3: 667-674.
14. Ledl A, Schmidt D, Muller S. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 2005; 24: 3810-3818.
15. Schwarze F, Meraner J, Lechner M, Loidl A, Stasyk T, Laich A et al. Cell cycle-dependent acetylation of Rb2/p130 in NIH3T3 cells. Oncogene 2010; 29: 5755-5760.
16. Kim HY, Ahn BY, Cho Y. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. Embo J 2001; 20: 295-304.
17. Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumoursuppressor pocket domain bound to a peptide from HPV E7. Nature 1998; 391: 859-865.
18. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden K et al. Cyclin encoded by KS herpesvirus. Nature 1996; 382: 410.
19. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA et al. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997; 71: 4193-4198.
20. Jung JU, Stager M, Desrosiers RC. Virus-encoded cyclin. Mol Cell Biol 1994; 14: 7235-7244.
21. Li M, Lee H, Yoon DW, Albrecht JC, Fleckenstein B, Neipel F et al. Kaposi's sarcomaassociated herpesvirus encodes a functional cyclin. J Virol 1997; 71: 1984-1991.
22. Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcomaassociated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000; 6: 1121-1127.
23. Moran E, Zerler B, Harrison TM, Mathews MB. Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol Cell Biol 1986; 6: 3470-3480.
24. Zhang B, Chen W, Roman A. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 2006; 103: 437-442.
25. Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC et al. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 2006; 281: 36221-36227.
26. Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, Gonzalez-Santamaria J, Gonzalez D et al. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. J Gen Virol 92(Part 1): 188-194.
27. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G et al. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 1994; 54: 5556-5560.
28. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991; 67: 293-302.
29. Starostik P, Chow KN, Dean DC. Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol 1996; 16: 3606-3614.
30. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 1993; 7: 1111-1125.
31. Melchior F. SUMO - nonclassical ubiquitin. Annu Rev Cell Dev Biol 2000; 16: 591-626.
32. Weinberg RA. The molecular basis of oncogenes and tumor suppressor genes. Ann NY Acad Sci 1995; 758: 331-338.
33. Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M et al. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene 2001; 20: 4827-4841.
34. Barbeau D, Charbonneau R, Whalen SG, Bayley ST, Branton PE. Functional interactions within adenovirus E1A protein complexes. Oncogene 1994; 9: 359-373.
35. Dyson N, Guida P, McCall C, Harlow E. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J Virol 1992; 66: 4606-4611.
36. Sullivan CS, Cantalupo P, Pipas JM. The molecular chaperone activity of simian virus 40 large T antigen is required to disrupt Rb-E2F family complexes by an ATP-dependent mechanism. Mol Cell Biol 2000; 20: 6233-6243.
37. Zalvide J, Stubdal H, DeCaprio JA. The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Mol Cell Biol 1998; 18: 1408-1415.
38. Araki K, Ahmad SM, Li G, Bray Jr. DA, Saito K, Wang D et al. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14: 3514-3519.
39. Bowen C, Spiegel S, Gelmann EP. Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res 1998; 58: 3275-3281.
40. Hsieh JK, Chan FS, O'Connor DJ, Mittnacht S, Zhong S, Lu X. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell 1999; 3: 181-193.
41. Knudsen KE, Weber E, Arden KC, Cavenee WK, Feramisco JR, Knudsen ES. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene 1999; 18: 5239-5245.
42. Lemaire C, Godefroy N, Costina-Parvu I, Rincheval V, Renaud F, Trotot P et al. Caspase-9 can antagonize p53-induced apoptosis by generating a p76(Rb) truncated form of Rb. Oncogene 2005; 24: 3297-3308.
43. Zhao X, Day ML. RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells. Urology 2001; 57: 860-865.
44. Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 2001; 75: 429-438.
45. Esteban M, Garcia MA, Domingo-Gil E, Arroyo J, Nombela C, Rivas C. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. J Gen Virol 2003; 84(Pt 6): 1463-1470.
46. Marcos-Villar L, Lopitz-Otsoa F, Gallego P, Munoz-Fontela C, Gonzalez-Santamaria J, Campagna M et al. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol 2009; 83: 8849-8858.
47. Shin YC, Joo CH, Gack MU, Lee HR, Jung JU. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res 2008; 68: 1751-1759.
48. Baresova P, Pitha PM, Lubyova B. Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability. J Biol Chem 2012; 287: 16199-16208.
49. Lubyova B, Kellum MJ, Frisancho JA, Pitha PM. Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus. J Biol Chem 2007; 282: 31944-31953.
50. Seo T, Park J, Lim C, Choe J. Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus. Oncogene 2004; 23: 6146-6155.
51. Joo CH, Shin YC, Gack M, Wu L, Levy D, Jung JU. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcomaassociated herpesvirus viral IRF homolog vIRF3. J Virol 2007; 81: 8282-8292.
52. Lubyova B, Kellum MJ, Frisancho AJ, Pitha PM. Kaposi's sarcoma-associated herpesvirus- encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 2004; 279: 7643-7654.
53. Wies E, Hahn AS, Schmidt K, Viebahn C, Rohland N, Lux A et al. The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J Biol Chem 2009; 284: 8525-8538.
54. Wies E, Mori Y, Hahn A, Kremmer E, Sturzl M, Fleckenstein B et al. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood 2008; 111: 320-327.
55. Christensen JB, Imperiale MJ. Inactivation of the retinoblastoma susceptibility protein is not sufficient for the transforming function of the conserved region 2- like domain of simian virus 40 large T antigen. J Virol 1995; 69: 3945-3948.
56. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006; 6: 739-748.
57. Wirt SE, Sage J. p107 in the public eye: an Rb understudy and more. Cell Div 2010; 5: 9.
58. Beijersbergen RL, Hijmans EM, Zhu L, Bernards R. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. Embo J 1994; 13: 4080-4086.
59. Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107. Science 1994; 264: 251-254.
60. Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 2007; 97: 81-109.
61. Pantry SN, Medveczky PG. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin Cancer Biol 2009; 19: 153-157.
62. Benetti R, Gonzalo S, Jaco I, Munoz P, Gonzalez S, Schoeftner S et al. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 2008; 15: 268-279.
63. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 2010; 84: 2697-2706.
64. Platt G, Carbone A, Mittnacht S. p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene 2002; 21: 1823-1831.
65. Claudio PP, Howard CM, Fu Y, Cinti C, Califano L, Micheli P et al. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res 2000; 60: 8-12.
66. Claudio PP, Howard CM, Pacilio C, Cinti C, Romano G, Minimo C et al. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res 2000; 60: 372-382.
67. Howard CM, Claudio PP, De Luca A, Stiegler P, Jori FP, Safdar NM et al. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/ p130, p27Kip1, and cyclin E negative feedback regulatory loop. Cancer Res 2000; 60: 2737-2744.
68. Scambia G, Lovergine S, Masciullo V. RB family members as predictive and prognostic factors in human cancer. Oncogene 2006; 25: 5302-5308.
69. Yeung RS, Bell DW, Testa JR, Mayol X, Baldi A, Grana X et al. The retinoblastomarelated gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene 1993; 8: 3465-3468.
70. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998; 2: 233-239.
71. Treier M, Staszewski LM, Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 1994; 78: 787-798.
72. Vertegaal AC, Andersen JS, Ogg SC, Hay RT, Mann M, Lamond AI. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics 2006; 5: 2298-2310.
73. Campagna M, Herranz D, Garcia MA, Marcos-Villar L, Gonzalez-Santamaria J, Gallego P et al. SIRT1 stabilizes PML promoting its sumoylation. Cell Death Differ 2011; 18: 72-79.